Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:319552OMIM:614891D84.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency (also called complete interleukin-12 receptor beta-1 deficiency) is a rare inherited immune system disorder. People with this condition have a weakened ability to fight off certain types of infections, particularly those caused by mycobacteria. Mycobacteria include the germs that cause tuberculosis (TB) and a group of usually harmless environmental bacteria called nontuberculous mycobacteria (NTM). In healthy people, these environmental mycobacteria rarely cause illness, but in individuals with this deficiency, they can cause serious, widespread infections. The condition is also associated with increased vulnerability to Salmonella bacteria and certain fungal infections like candidiasis. The IL12RB1 gene provides instructions for making a protein that is part of the receptor for two important immune signaling molecules: interleukin-12 (IL-12) and interleukin-23 (IL-23). When this receptor is completely absent, immune cells — especially T cells and natural killer cells — cannot properly produce interferon-gamma, a critical molecule needed to activate macrophages that kill mycobacteria and other intracellular germs. This leaves the body unable to mount an effective defense against these specific infections. Symptoms typically begin in early childhood, often after BCG vaccination (a live vaccine against tuberculosis given in many countries) or after exposure to environmental mycobacteria. Infections can affect the lymph nodes, lungs, bones, skin, and sometimes spread throughout the body. Treatment focuses on aggressive and prolonged antibiotic therapy for infections, and in some cases, supplemental interferon-gamma therapy. Hematopoietic stem cell transplantation (bone marrow transplant) may be considered in severe cases as a potentially curative option.

Also known as:

Key symptoms:

Severe or widespread infection after BCG vaccinationRecurrent or persistent infections with environmental mycobacteriaSwollen and infected lymph nodesChronic lung infectionsBone infections (osteomyelitis)Skin infections or abscessesRecurrent Salmonella infectionsPersistent feversWeight loss or failure to thrive in childrenChronic diarrhea from gut infectionsFungal infections such as oral thrush or candidiasisFatigue and general weaknessInfections that spread to multiple organs (disseminated disease)

Clinical phenotype terms (15)— hover any for plain English
Abnormal circulating interleukin concentrationHP:0011117Recurrent mycobacterial infectionsHP:0011274Disseminated nontuberculous mycobacterial infectionHP:0032283Salmonella osteomyelitisHP:0005661Recurrent candida infectionsHP:0005401Tegumentary leishmaniasis susceptibilityHP:0007408LymphadenitisHP:0002840BCGosisHP:0020087Vasculitis in the skinHP:0200029Recurrent Klebsiella infectionsHP:0002742HistoplasmosisHP:0032256CoccidioidomycosisHP:0032249Severe toxoplasmosisHP:0020105
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Childhood

Begins in childhood, roughly ages 1 to 12

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency.

View clinical trials →

No actively recruiting trials found for Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency community →

No specialists are currently listed for Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiencyForum →

No community posts yet. Be the first to share your experience with Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency.

Start the conversation →

Latest news about Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency

No recent news articles for Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.How severe is my child's immune deficiency, and what infections should we watch for most closely?,Should my child receive interferon-gamma therapy, and what are the benefits and risks?,Is bone marrow transplant recommended for my child, and what would that process involve?,Which vaccines are safe and which should be avoided?,What preventive antibiotics should my child take, and for how long?,How should we handle fevers or signs of infection — when should we go to the emergency room?,Should other family members be tested for this genetic condition?

Common questions about Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency

What is Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency?

Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency (also called complete interleukin-12 receptor beta-1 deficiency) is a rare inherited immune system disorder. People with this condition have a weakened ability to fight off certain types of infections, particularly those caused by mycobacteria. Mycobacteria include the germs that cause tuberculosis (TB) and a group of usually harmless environmental bacteria called nontuberculous mycobacteria (NTM). In healthy people, these environmental mycobacteria rarely cause illness, but in individuals with this deficienc

How is Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency inherited?

Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency typically begin?

Typical onset of Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency is childhood. Age of onset can vary across affected individuals.